Meda Articles
Jazz Pharma sells women's health business to Meda for $95 million
7 September 2012
Meda's Zyclara approved in the EU
29 August 2012
Perrigo confirms ANDA filing for generic Astepro nasal spray
24 January 2012
EU Commission clears KKR acquisition of Pfizer Capsugel unit; Meda says no approach from Valeant
28 July 2011
Crucell M&A update; Meda buys Antula; Bayer eyes pharma boost
22 February 2011
EMA advisory committee backs Gilenya, Halaven, Jevtana, Pravafenix and Trobalt, but negatives for Fampyra and Multaq
24 January 2011
Meda debuts leukemia drug Ceplene in the UK
20 January 2011
Commission clears JV by DocMorris and K-Mail Order; OK’s Pfizer’s pediatric Xalatan and Meda’s Breakyl
22 October 2010
Sweden’s Meda buys US specialty drug firm Alaven for $350 million
1 September 2010
Showing 1-18 of 18 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
